Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of IL-6 Promoter and Receptor Polymorphisms with Multiple Myeloma Risk: A Systematic Review and Meta-Analysis.

Genetic testing and molecular biomarkers - 1 Oct 2016

Li Yuying, Du Zhonghua, Wang Xu, Wang Guanjun, Li Wei

Abstract excerpt

BACKGROUND: A number of studies show that the pleiotropic cytokine interleukin-6 (IL-6) plays an important role in the pathogenesis of multiple myeloma (MM). However, whether MM risk is associated with IL-6 genetic variability remains uncertain. OBJECTIVE: The aim of our study was to evaluate the association between two different IL-6 polymorphisms (located in the IL-6 promoter and receptor, respectively) and the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic Predisposition to Disease
Share to Interleukin-6

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multiple Myeloma

Share to Neoplasm Proteins

Share to Polymorphism, Genetic

Share to Promoter Regions, Genetic

Share to Receptors, Interleukin-6

Source

Identifiers

PMID: 27525545
DOI: 10.1089/gtmb.2015.0169

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of IL-6 Promoter and Receptor Polymorphisms with Multiple Myeloma Risk: A Systematic Review and Meta-Analysis.PMID 27525545Read ↗

Interleukin-6 gene-174 G/C promoter polymorphism and its association with clinical profile of patients with multiple myeloma.Semantic proximity Read ↗

Interleukin-6 gene-174 G/C promoter polymorphism is not associated with multiple myeloma susceptibility: evidence from meta-analysis: A systematic review and meta-analysis.Semantic proximity Read ↗

Analysis of polymorphism at site -174 G/C of interleukin-6 promoter region in multiple myeloma.Semantic proximity Read ↗

Genetic polymorphisms and multiple myeloma risk: a meta-analysis.Semantic proximity Read ↗

IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma.Semantic proximity Read ↗

Interleukin 6, tumour necrosis factor α, interleukin 1β and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myelomaSemantic proximity Read ↗

Interleukin-6 polymorphisms and hematologic malignancy: a re-appraisal of evidence from genetic association studies.Semantic proximity Read ↗

Effect of Cytokine Genes in the Pathogenesis and on the Clinical Parameters for the Treatment of Multiple Myeloma.Semantic proximity Read ↗

Interleukin-6-related genotypes, body mass index, and risk of multiple myeloma and plasmacytoma.Semantic proximity Read ↗

Role of cytokines in multiple myeloma: IL-1RN and IL-4 VNTR polymorphisms.Semantic proximity Read ↗

An intermediate-risk multiple myeloma subgroup is defined by sIL-6r: levels synergistically increase with incidence of SNP rs2228145 and 1q21 amplification.Semantic proximity Read ↗

Association Of -308G/A, -238G/A TNF-α Polymorphisms with Multiple Myeloma Risk and Survival: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.